Akso Health Group (AHG) Stock Price, News & Analysis

Company Overview

Akso Health Group (NASDAQ:AHG) is a leading integrated healthcare services company focused on the distribution of pharmaceuticals, medical supplies, and medical devices. Through its comprehensive logistics network and proprietary e-commerce platform, the company supplies hospital systems, clinics, pharmacies, and government entities with a broad portfolio of branded and generic medicines, surgical instruments, diagnostic equipment, and vaccines.

Founded in 1997 under the name MAPS, the company expanded its capabilities through strategic acquisitions and the development of specialized distribution channels for temperature-sensitive products and laboratory reagents. In 2023, MAPS rebranded as Akso Health Group to reflect its broader scope of services, which now includes supply chain optimization, cold chain logistics, and digital health solutions designed to streamline procurement and inventory management processes for healthcare providers.

Headquartered in Istanbul, Akso Health Group serves customers across Turkey as well as in the Middle East, North Africa, and parts of Eastern Europe, operating from a network of distribution centers equipped to handle both ambient and cold chain products. The company’s global reach is supported by partnerships with international manufacturers and local regulatory expertise, enabling it to navigate complex cross-border trade and compliance requirements effectively.

The leadership team at Akso Health Group brings together seasoned professionals from the pharmaceutical and logistics sectors, led by CEO Önder Akso. Under their guidance, the company continues to invest in technology-driven solutions and sustainable practices aimed at enhancing supply chain resilience and expanding its footprint in emerging markets.

Key Stats

• Today's Range: $1.84 to $1.99
• 50-Day Range: $1.13 to $1.94
• 52-Week Range: $0.74 to $2.35
• Volume: 19,332 shs
• Average Volume: 69,507 shs
• Market Capitalization: $278.33 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Akso Health Group Stock Analysis - MarketRank™

Akso Health Group scored higher than 2% of companies evaluated by MarketBeat, and ranked 206th out of 207 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Akso Health Group.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Akso Health Group has a P/B Ratio of 2.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.02% of the float of Akso Health Group has been sold short.

Short Interest Ratio / Days to Cover

Akso Health Group has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Akso Health Group has recently increased by 23.22%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Akso Health Group does not currently pay a dividend.

Dividend Growth

Akso Health Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.02% of the float of Akso Health Group has been sold short.

Short Interest Ratio / Days to Cover

Akso Health Group has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Akso Health Group has recently increased by 23.22%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Akso Health Group this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for AHG on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Akso Health Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 1.21% of the stock of Akso Health Group is held by institutions.

AHG Stock Analysis - Frequently Asked Questions

How have AHG shares performed this year?

Akso Health Group's stock was trading at $1.36 on January 1st, 2025. Since then, AHG shares have increased by 40.4% and is now trading at $1.91.

How do I buy shares of Akso Health Group?

Shares of AHG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Akso Health Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Akso Health Group investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Meta Platforms (META).

Company Calendar

• Today: 7/20/2025
• Next Earnings (Estimated): 7/29/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: INTERNET COMMERCE
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:AHG
• CIK: 1702318
• Web: ir.xiaobaimaimai.com
• Phone: 861053709902
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $2.41 million
• Price / Sales: 115.49
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.95 per share
• Price / Book: 2.01

Miscellaneous

• Outstanding Shares: 145,720,000
• Free Float: N/A
• Market Cap: $278.33 million
• Optionable: Not Optionable
• Beta: -0.70